Biotinoyl Tripeptide-1

Biotinoyl Tripeptide-1 is a synthetic peptide that combines biotin (Vitamin H) with a tripeptide (Glycine-Histidine-Lysine). Its research applications primarily focus on its potential role in stimulating cellular growth, particularly in the context of hair follicle vitality and extracellular matrix synthesis. Its proposed mechanisms of action include:

• Hair Follicle Stimulation: Research suggests that Biotinoyl Tripeptide-1 can influence the anagen (growth) phase of hair follicles. It is thought to promote the proliferation of hair bulb keratinocytes and enhance the expression of adhesion molecules, which are crucial for anchoring hair to the scalp.
• Extracellular Matrix (ECM) Synthesis: The peptide component (GHK) is known to play a role in tissue remodeling and the synthesis of ECM proteins like collagen and laminin-5. By enhancing ECM production around the hair follicle, it may contribute to stronger, more resilient hair growth.
• Increased Microcirculation: Some studies indicate a potential to improve blood circulation to the hair follicles, ensuring a better supply of nutrients and oxygen essential for healthy hair growth.
• Anti-Apoptotic Effects: It may also exert anti-apoptotic (anti-cell death) effects on hair follicle cells, prolonging their life cycle and promoting sustained hair growth.

These mechanisms make Biotinoyl Tripeptide-1 a compelling subject for researchers investigating hair biology, alopecia, and cosmetic formulations for hair and scalp health.

Biotinoyl Tripeptide-1 is predominantly a subject of **preclinical research** within the cosmetic science and dermatology fields, focusing on its potential applications in hair and lash growth. While widely incorporated into various hair care and eyelash growth formulations (often under trade names like Procapil, which is a blend including this peptide), its "clinical development" typically refers to studies by cosmetic manufacturers to support product claims rather than formal pharmaceutical drug approvals.

• Hair Growth and Anti-Hair Loss: Extensive research evaluates its efficacy in promoting hair growth, reducing hair loss, and improving hair density and thickness in models of alopecia (e.g., androgenetic alopecia, telogen effluvium).
• Eyelash and Eyebrow Enhancement: Studies investigate its potential to promote the growth and density of eyelashes and eyebrows, a common application in cosmetic products.
• Hair Follicle Biology: In vitro and ex vivo studies are conducted on dermal papilla cells and hair follicles to understand its impact on cell proliferation, survival, and gene expression related to hair growth cycles.
• Scalp Health: Research may also explore its broader benefits for scalp health, including potential anti-inflammatory or revitalizing effects.
• Formulation Stability and Delivery: Studies focus on optimizing its stability in topical formulations and ensuring effective penetration to the hair follicle bulb.

It's important to recognize that while widely used in cosmetic science, Biotinoyl Tripeptide-1 is strictly for laboratory research purposes as supplied and is not approved by regulatory bodies for therapeutic or diagnostic use in humans.

Biotinoyl Tripeptide-1 is strictly intended for **laboratory research purposes only**. It must be handled by qualified research personnel in a controlled laboratory environment, adhering to all applicable safety protocols and guidelines for investigational research chemicals. This product is **not approved for human consumption, therapeutic use, or veterinary applications**. Its use is limited to scientific investigation and analysis. Proper laboratory safety equipment, including personal protective equipment (PPE), and procedures must be employed during its handling, storage, and experimental application. Researchers should consult relevant safety data sheets (SDS) and institutional guidelines before use.

For more detailed information on **Biotinoyl Tripeptide-1** and its research applications, please refer to the following scientific literature and related reviews:

• Maurelli V, et al. "Topical treatment of androgenetic alopecia: A systematic review." J Cosmet Dermatol. 2012; PMID: 22934579 (Review mentioning efficacy of formulations including Biotinoyl Tripeptide-1)
• Trüeb RM. "The value of biotinoyl tripeptide-1 in hair care." J Cosmet Sci. 2013; DOI:10.1007/s00403-013-1383-x (Review focusing on this peptide in hair care)
• Cosmetic peptides: an updated review: J Cosmet Dermatol, PMID: 24707168 (General review of cosmetic peptides and their functions)
• PubChem Compound Summary: Biotinoyl Tripeptide-1 (CID 11534242)
• Procapil™ product page - Sederma (Manufacturer's page for a blend containing Biotinoyl Tripeptide-1, detailing in-vitro and ex-vivo studies)

*(Note: Direct, independent peer-reviewed publications specifically on "Biotinoyl Tripeptide-1" by its generic name may be limited as it is often part of proprietary formulations. General peptide research and reviews provide broader scientific context.)*

This product, Biotinoyl Tripeptide-1, is sold exclusively for **research and development purposes**. It is classified as a research chemical and is **not a drug, food, or cosmetic**. It has not been evaluated or approved by the FDA or any other regulatory authority for safety, efficacy, or any other use in humans or animals. By purchasing this product, the user acknowledges and agrees to comply with all applicable local, national, and international laws and regulations regarding the handling, storage, and use of research compounds. Any use of this product for purposes other than legitimate scientific research is strictly prohibited and may lead to severe legal and health consequences.